We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Ohr Pharmaceutical Awarded Key Canadian Composition-of-Matter Patent on OHR/AVR118

News   May 18, 2011

 
Ohr Pharmaceutical Awarded Key Canadian Composition-of-Matter Patent on OHR/AVR118
 
 
 

RELATED ARTICLES

Women With Sleep Apnea More Likely to Be Diagnosed With Cancer Than Men

News

A recent study shows that women with obstructive sleep apnea (OSA) are more likely to be diagnosed with cancer than men with the condition

READ MORE

Why Some Sufferers of Chronic Infections Wither Away

News

Researchers showed that some chronic viral infection led to a severe reorganization of the architecture of the fat tissue and cachexiain triggered by CD8+ T cells.

READ MORE

Diagnosing Lung Cancer With Artificial Intelligence

News

A new study reports that deep learning — a form of artificial intelligence — was able to detect malignant lung nodules on low-dose chest computed tomography scans with a performance meeting or exceeding that of expert radiologists.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE